<VariationArchive VariationID="586238" VariationName="NM_001009944.3(PKD1):c.10167+25_10167+43del" VariationType="Deletion" Accession="VCV000586238" Version="33" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-23" DateCreated="2018-10-20" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="577473" VariationID="586238">
      <GeneList>
        <Gene Symbol="PKD1" FullName="polycystin 1, transient receptor potential channel interacting" GeneID="5310" HGNC_ID="HGNC:9008" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2088708" stop="2135898" display_start="2088708" display_stop="2135898" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NT_187607.1" start="705067" stop="760109" display_start="705067" display_stop="760109" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2138710" stop="2185898" display_start="2138710" display_stop="2185898" Strand="-" />
          </Location>
          <OMIM>601313</OMIM>
          <Haploinsufficiency last_evaluated="2020-06-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PKD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-06-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PKD1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001009944.3(PKD1):c.10167+25_10167+43del</Name>
      <CanonicalSPDI>NC_000016.10:2097824:CAGGACCCCCAGCCCAGCCCAGGACCCCCAG:CAGGACCCCCAG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2097825" stop="2097843" display_start="2097825" display_stop="2097843" variantLength="19" positionVCF="2097824" referenceAlleleVCF="GCAGGACCCCCAGCCCAGCC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2147826" stop="2147844" display_start="2147826" display_stop="2147844" variantLength="19" positionVCF="2147825" referenceAlleleVCF="GCAGGACCCCCAGCCCAGCC" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.2097837_2097855del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.2097837_2097855del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.2147838_2147856del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.2147838_2147856del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008617.1" sequenceAccession="NG_008617" sequenceVersion="1" change="g.45378_45396del">
            <Expression>NG_008617.1:g.45378_45396del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000296.4" sequenceAccession="NM_000296" sequenceVersion="4" change="c.10167+25_10167+43del">
            <Expression>NM_000296.4:c.10167+25_10167+43del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001009944.3" sequenceAccession="NM_001009944" sequenceVersion="3" change="c.10167+25_10167+43del" MANESelect="true">
            <Expression>NM_001009944.3:c.10167+25_10167+43del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1197421698" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001009944.3(PKD1):c.10167+25_10167+43del AND not provided" Accession="RCV000712572" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-01-18" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001009944.3(PKD1):c.10167+25_10167+43del AND Polycystic kidney disease, adult type" Accession="RCV002272336" Version="7">
        <ClassifiedConditionList TraitSetID="6385">
          <ClassifiedCondition DB="MedGen" ID="C3149841">Polycystic kidney disease, adult type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-02-23" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001009944.3(PKD1):c.10167+25_10167+43del AND Autosomal dominant polycystic kidney disease" Accession="RCV003229563" Version="1">
        <ClassifiedConditionList TraitSetID="13731">
          <ClassifiedCondition DB="MedGen" ID="C0085413">Autosomal dominant polycystic kidney disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-20" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-23" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2018-10-20" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22008521</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9199561</ID>
        </Citation>
        <DescriptionHistory Dated="2023-05-29">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13731" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16746" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant polycystic kidney disease</ElementValue>
                <XRef ID="MONDO:0004691" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ADPKD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10413" />
                <XRef ID="10413" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant polycystic kidney disease (ADPKD) is generally a late-onset multisystem disorder characterized by bilateral kidney cysts, liver cysts, and an increased risk of intracranial aneurysms. Other manifestations include: cysts in the pancreas, seminal vesicles, and arachnoid membrane; dilatation of the aortic root and dissection of the thoracic aorta; mitral valve prolapse; and abdominal wall hernias. Kidney manifestations include early-onset hypertension, kidney pain, and kidney insufficiency. Approximately 50% of individuals with ADPKD have end-stage kidney disease (ESKD) by age 60 years. The prevalence of liver cysts increases with age and occasionally results in clinically significant severe polycystic liver disease (PLD), most often in females. Overall, the prevalence of intracranial aneurysms is fivefold higher than in the general population and further increased in those with a positive family history of aneurysms or subarachnoid hemorrhage. There is substantial variability in the severity of kidney disease and other extra-kidney manifestations.</Attribute>
                <XRef ID="NBK1246" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301424</ID>
                <ID Source="BookShelf">NBK1246</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA/ASA, 2014">
                <ID Source="PubMed">25355838</ID>
              </Citation>
              <Citation Type="general" Abbrev="Spanish WG, 2014">
                <ID Source="PubMed">25165191</ID>
              </Citation>
              <XRef ID="730" DB="Orphanet" />
              <XRef ID="C0085413" DB="MedGen" />
              <XRef ID="MONDO:0004691" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6385" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3359" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Polycystic kidney disease, adult type</ElementValue>
                <XRef ID="Polycystic+kidney+disease%2C+adult+type/9125" DB="Genetic Alliance" />
                <XRef ID="28728008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE</ElementValue>
                <XRef Type="MIM" ID="173900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycystic Kidney, Autosomal Dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycystic kidney disease 1</ElementValue>
                <XRef ID="MONDO:0008263" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycystic kidney disease 1, severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE I</ElementValue>
                <XRef Type="MIM" ID="173900" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PKD1</ElementValue>
                <XRef Type="MIM" ID="173900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">APKD1</ElementValue>
                <XRef Type="MIM" ID="173900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant polycystic kidney disease (ADPKD) is generally a late-onset multisystem disorder characterized by bilateral kidney cysts, liver cysts, and an increased risk of intracranial aneurysms. Other manifestations include: cysts in the pancreas, seminal vesicles, and arachnoid membrane; dilatation of the aortic root and dissection of the thoracic aorta; mitral valve prolapse; and abdominal wall hernias. Kidney manifestations include early-onset hypertension, kidney pain, and kidney insufficiency. Approximately 50% of individuals with ADPKD have end-stage kidney disease (ESKD) by age 60 years. The prevalence of liver cysts increases with age and occasionally results in clinically significant severe polycystic liver disease (PLD), most often in females. Overall, the prevalence of intracranial aneurysms is fivefold higher than in the general population and further increased in those with a positive family history of aneurysms or subarachnoid hemorrhage. There is substantial variability in the severity of kidney disease and other extra-kidney manifestations.</Attribute>
                <XRef ID="NBK1246" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18597" />
                <XRef ID="18597" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301424</ID>
                <ID Source="BookShelf">NBK1246</ID>
              </Citation>
              <XRef ID="C3149841" DB="MedGen" />
              <XRef ID="MONDO:0008263" DB="MONDO" />
              <XRef Type="MIM" ID="173900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1641374" SubmissionDate="2019-09-25" DateLastUpdated="2018-10-20" DateCreated="2018-10-20">
        <ClinVarSubmissionID localKey="13311|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000843088" DateUpdated="2018-10-20" DateCreated="2018-10-20" Type="SCV" Version="2" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9199561</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22008521</ID>
          </Citation>
          <Comment>Not found in the total gnomAD dataset, and the data is high quality (0/276184 chr). Found in at least one symptomatic patient. Not predicted to affect natural splicing. Damaging to protein function(s) relevant to disease mechanism. Two de novo cases without parental identity confirmed.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000296.3:c.10167+25_10167+43del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6347501</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5022102" SubmissionDate="2022-07-12" DateLastUpdated="2022-09-03" DateCreated="2022-09-03">
        <ClinVarSubmissionID localKey="53611560|OMIM:173900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002568126" DateUpdated="2022-09-03" DateCreated="2022-09-03" Type="SCV" Version="1" SubmitterName="Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center" OrgID="1019" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PS4_Moderate, PM2, PS3_Very Strong</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001009944.3:c.10167+25_10167+43del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="173900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11782039</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5391393" SubmissionDate="2022-11-27" DateLastUpdated="2023-06-03" DateCreated="2023-06-03">
        <ClinVarSubmissionID localKey="RBW401|MONDO:4691" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002756456" DateUpdated="2023-06-03" DateCreated="2023-06-03" Type="SCV" Version="1" SubmitterName="Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research" OrgID="507627" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Whole Genome Sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001009944.2:c.10167+25_10167+43del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0004691" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12331097</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5027015" SubmissionDate="2023-01-25" DateLastUpdated="2023-02-07" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="GDXSV:256908" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002571259" DateUpdated="2023-02-07" DateCreated="2022-09-17" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Non-canonical splice site variant demonstrated to result in loss-of-function (Peral et al., 1997); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9199561, 22508176, 22008521, 22383692)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="16" alternateAllele="-" referenceAllele="CAGGACCCCCAGCCCAGCC" start="2147826" stop="2147844" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2103111</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_129_20220914054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_161_20230125054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7167675" SubmissionDate="2023-03-09" DateLastUpdated="2023-03-18" DateCreated="2023-03-18">
        <ClinVarSubmissionID localKey="NM_001009944.2(PKD1):c.10167+25_10167+43del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003839857" DateUpdated="2023-03-18" DateCreated="2023-03-18" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-30">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>DNA sequence analysis of the PKD1 gene demonstrated a 19 base pair deletion in intron 31, c.10167+25_10167+43del. The c.10167+25_10167+43del sequence change has not been described in population databases such as ExAC and gnomAD (dbSNP rs1197421698). This pathogenic sequence change has previously been described in individuals with polycystic kidney disease (PMID: 9199561, 22008521, 22508176, 22383692). Analysis of this variant demonstrated aberrant splicing and the inclusion of a deleted intron which results in an amino acid frameshift that creates a premature stop codon 30 amino acids downstream of position 3390 (PMID: 9199561). Based on these collective evidences, this sequence change is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001009944.2:c.10167+25_10167+43del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12941816</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7171809" SubmissionDate="2023-03-09" DateLastUpdated="2023-03-18" DateCreated="2023-03-18">
        <ClinVarSubmissionID localKey="16-2147825-GCAGGACCCCCAGCCCAGCC-G" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003842136" DateUpdated="2023-03-18" DateCreated="2023-03-18" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22008521</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9199561</ID>
          </Citation>
          <Comment>The variant is not observed in the gnomAD v2.1.1 dataset. Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID: 9199561). The variant has been observed in at least two similarly affected unrelated individuals (PMID: 22008521, 9199561). The variant has been previously reported as assumed (i.e. paternity and maternity not confirmed) de novo in at least two similarly affected unrelated individuals (PMID: 9199561 / SCV000843088.2). The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (PMID: 9199561). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001635" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001009944.3:c.10167+25_10167+43del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="173900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12919228</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5003423" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001009944_2_PKD1_c_10167_25_10167_43delCAGGACCCCCAGCCCAGCC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002557617" DateUpdated="2024-07-23" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9199561</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22008521</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. Predominantly caused by monoallelic variants, with rare reports of biallelic variants causing disease. (N) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (exon 32 of 46). (P) 0210 - Intronic variant proven to affect splicing of the transcript with a known effect on protein structure. RT-PCR demonstrated inclusion of part of the intronic region, causing a frameshift which introduced a premature termination codon 30 amino acids downstream of position 3390 (PMID: 9199561). (N) 0251 - Variant is heterozygous. (N) 0302 - Variant is present in gnomAD &lt;0.001 for a dominant condition (1 heterozygote, 0 homozygotes). (P) 0701 - Comparable variants have very strong previous evidence for pathogenicity. Other variants predicted to cause NMD have been reported as pathogenic in individuals (ClinVar). (P) 0801 - Strong previous evidence of pathogenicity in unrelated individuals. The variant has been previously reported in multiple patients with polycystic kidney disease (ClinVar, PKD database, PMID: 9199561, 22008521). (P) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_2492</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001009944.2:c.10167+25_10167+43del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0008263" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_32</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7167675" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5022102" TraitType="Disease" MappingType="XRef" MappingValue="173900" MappingRef="OMIM">
        <MedGen CUI="C3149841" Name="Polycystic kidney disease, adult type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5003423" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0008263" MappingRef="MONDO">
        <MedGen CUI="C3149841" Name="Polycystic kidney disease, adult type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1641374" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5391393" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0004691" MappingRef="MONDO">
        <MedGen CUI="C0085413" Name="Autosomal dominant polycystic kidney disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171809" TraitType="Disease" MappingType="XRef" MappingValue="173900" MappingRef="OMIM">
        <MedGen CUI="C3149841" Name="Polycystic kidney disease, adult type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5027015" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171809" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001635" MappingRef="HP">
        <MedGen CUI="C0018802" Name="Congestive heart failure" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

